Key result
Responsive thromboplastins with an ISI close to 1.0 provide greater safety in anticoagulant dosage and equal precision to high ISI reagents when using the INR system.
Answers are grounded in this paper and cite their sources.
Standardizing prothrombin time reporting using the INR system demonstrates that thromboplastins with an ISI close to 1.0 offer comparable precision and greater safety for anticoagulant dosing.
Dr Easton makes two relevant comments regarding North American and United Kingdom quality control results in pro- thrombin time testing.The first is his surprise at the better precision of manual versus automated results in the United Kingdom surveys.The long established proficiency in the manual technique in the United King- dom is well recognised and may relate to the centralisation of coagulation procedures in the United Kingdom in district general hosp- itals and other large laboratories.The second point concerns the relative precision (CV) in prothrombin time testing obtained in recent United Kingdom and College of American Pathologists' (CAP) surveys.The CV is influenced by the dif- ference in sensitivity of reagents used in the United Kingdom compared with those in North America.The former, with ISI values close to 10, give considerably longer pro- thrombin times on Coumarin treatment and hence higher CV.For meaningful compar- ison of precision, however, the results must be expressed on a uniform scale using INR.We have shown that the CV of the INR approximates to the CV of the PT ratio x ISI.For example, with a thromboplastin with an ISI of 2-0 (most North American reagents have even higher ISI values), a CV of 4% for a prothrombin time expressed in seconds, quoted for the North American surveys by Dr Easton, increases to 8% when expressed as INR.In contrast, as most hospitals in the United Kingdom use a thromboplastin with an ISI of 1 1 the effect is relatively insignificant.Thus when results are reported as INR precision with this throm- boplastin is at least as good as with American reagents.Responsive thromboplastins with an ISI close to 1 0 have been shown to give greater safety in anticoagulant dosage.3They also provide at least equal precision in testing to high ISI reagents using the INR system, irrespectiive of whether a manual or automated technique is used.
No takes yet. Share an insight, caveat, or question.
A M van den Besselaar (1989) conducted a letter in Anticoagulant therapy monitoring. Responsive thromboplastins with an ISI close to 1.0 vs. High ISI reagents was evaluated. Responsive thromboplastins with an ISI close to 1.0 provide greater safety in anticoagulant dosage and equal precision to high ISI reagents when using the INR system.
Synapse has enriched 10 related papers. Consider them for comparative context: